LinkedIn Twitter Facebook

ISPOR 4th ASIA-PACIFIC CONFERENCE AWARDS WINNERS

By Stephen Priori, Director, ISPOR Publications

The ISPOR Best Research Podium and Poster Presentation Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, Asia-Pacific and Latin America Conferences.

At the ISPOR 4th Asia-Pacific Conference, the ISPOR Research Presentation Award judges evaluated 40 podium presentations and nominated posters from 290 poster presentations. All podium presentations are considered for an award. Poster presentations in the top 10%, based on abstract review score, are considered and eligible for a poster presentation award.

Evaluations of scientific merit were based upon the following criteria:

  • Background provides appropriate perspective / context for the subject
  • Objectives / research questions are clearly stated
  • Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
  • Data sources and/or sampling procedures are clear and appropriate
  • Data analyses are appropriate
  • Research objectives are met/addressed
  • Implications of findings are discussed
  • Factual information is kept separate from interpretations or implications
  • Abstract is presented in an unbiased manner
  • Clarity of presentation


THE RECIPIENTS  ARE: . . .

BEST PODIUM RESEARCH PRESENTATIONS

CV4
THE CLINICAL EFFECTIVENESS OF 64-SLICE OR HIGHER COMPUTED TOMOGRAPHY ANGIOGRAPHY AS AN ALTERNATIVE TO INVASIVE CORONARY ANGIOGRAPHY IN THE INVESTIGATION OF SUSPECTED CORONARY ARTERY DISEASE
Paech D, Weston A
Health Technology Analysts Pty Ltd, Sydney, NSW, Australia

 

DB3
LIFETIME CLINICAL PROJECTIONS FOR OVERWEIGHT OR OBESE SUBJECTS WITH IMPAIRED GLUCOSE INTOLERANCE BASED ON THE LONG TERM RESULTS OF THE DIABETES PREVENTION PROGRAM AND DIABETES PREVENTION PROGRAM OUTCOMES STUDY
Palmer AJ, Tucker DM
Menzies Research Institute, University of Tasmania, Hobart, Tasmania, Australia

 

HT3

COST-EFFECTIVENESS OF BLOOD PRESSURE LOWERING WITH A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN TYPE 2 DIABETES MELLITUS: A TRIAL-BASED ANALYSIS USING THE ADVANCE STUDY

Clarke PM1, Glasziou P2, Alexander J3, Chalmers J4, Patel A5

1University of Sydney, Sydney , NSW, Australia, 2University of Oxford, Oxford, Oxfordshire, UK, 3University of Queensland, Brisbane, Queensland, Australia, 4George Institute, Sydney, Australia, 5George Institute, Sydney, Australia

 

CN3

QUALITY OF LIFE IN ADVANCED CANCER PATIENT – COMPARISON OF PATIENT REPORTED OUTCOME (PRO) AND PROXIES ASSESSMENT

Choi J1, Miyashita M2, Kim B3
1National Evidence-based Healthcare Collaborating Agency (NECA), Seoul, South Korea, 2Tohoku University School of Health Sciences, Sendai, Japan, 3Hanyang University, Seoul, South Korea

DS3

A COMPARISON OF SIGNAL DETECTION PERFORMANCE BETWEEN REPORTING ODDS RATIO AND BAYESIAN CONFIDENCE PROPAGATION NEURAL NETWORK METHODS ON ADVERSE DRUG REACTION SPONTANEOUS REPORTING DATABASE OF THE THAI FDA

Bunchuailua W1, Zuckerman I2, Kulsomboon V3, Suwankesawong W4, Singhasivanon P5, Kaewkungwal J5
1Faculty of Pharmacy Silpakorn University, Muang, Nakhon Pathom, Thailand, 2University of Maryland, Baltimore, Baltimore, MD, USA, 3Chulalongkorn University, Bangkok, Thailand, 4Food and Drug Administration, Muang, Nonthaburi, Thailand, 5Faculty of Tropical Medicine Mahidol University, Ratchawithi, Bangkok, Thailand

DU2

THE UTILIZATION OF PROPHYLACTIC ANTITHROMBOTIC AGENTS AFTER MAJOR ORTHOPEDIC SURGERIES- A POPULATION-BASED STUDY IN TAIWAN

Yu YY1, Chen LC1, Cheng LJ2
1Kaohsiung Medical University, Kaohsiung, Taiwan, 2University of Macau, Macau

BEST POSTER RESEARCH PRESENTATIONS

PIN20

A MODELLED ECONOMIC EVALUATION OF RALTEGRAVIR COMPARED TO STANDARD PRACTICE IN AUSTRALIA FOR TREATMENT NAÏVE PATIENTS WITH HIV

Tilden D1, Jackson D1, LeReun C2, Harvey C3, Price B3, Chaudhary M4, van Bavel J3
1THEMA Pty Ltd, Sydney, NSW, Australia, 2Independent Biostatistician, Carrigaline, Cork, Ireland, 3MSD, Sydney, NSW, Australia, 4Merck, Upper Gwynedd, PA, USA

 

PCN21

COST-EFFECTIVENESS ANALYSIS OF ADJUVANT HORMONAL TREATMENTS FOR POSTMENOPAUSAL HORMONE-RECEPTOR POSITIVE EARLY BREAST CANCER IN KOREAN CONTEXT

Lee HJ, Lee TJ, Yang BM
Seoul National University, Seoul, South Korea

 

PIH7

ECONOMIC EVALUATION OF HUMAN PAPILLOMAVIRUS (HPV) VACCINATIONS IN THE PREVENTION OF CERVICAL CANCER

Wan Puteh SE
National University of Malaysia, Kuala Lumpur Malaysia, Kuala Lumpur, Malaysia

 

PMH2

EARLY RESPONSE PREDICTS SUBSEQUENT RESPONSE TO OLANZAPINE LONG-ACTING INJECTIONS IN THE TREATMENT OF SCHIZOPHRENIA

Ascher-Svanum H1, Zhao F1, Nyhuis A1, Lawson AH1, Stauffer VL2, Montgomery W3, Witte M2, Detke H1, McDonnell DP4
1Eli Lilly and Company, Indianapolis, IN, USA, 2Lilly USA, LLC, Indianapolis, IN, USA, 3Eli Lilly and Company, West Ryde, NSW, Australia, 4Eli Lilly and Company, Cork, Ireland

PUK5

COMPARISON OF SF-6D, EQ-5D AND VAS IN HEMODIALYSIS THAI PATIENT

Thaweethamcharoen T1, Sakulbumrungsil R2, Vasuvattakul S1, Nopmaneejumruslers C1
1Mahidol University, Bangkok, Thailand, 2Chulalongkorn University, Bangkok, Thailand

 

PDB19

HEALTH-RELATED QUALITY OF LIFE AND GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Shim YT1, Ko Y1, Lee JYC1, Tang WE2, Toh MPHS2

1National University of Singapore, Singapore 2National Healthcare Group Polyclinics, Singapore, Singapore

 

ISPOR would like to thank all the judges who have volunteered their time and efforts during the meeting to score podium and poster presentations.
 

 

Return to ISPOR Awards Index Page
 

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2012 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.
 
Website design by Eagle Systems USA, Inc.